Brief: Atricure’S Epi-Sense System Approved By FDA For Treatment Of Long-Standing Persistent Afib Patients

AtriCure

29/04/2021 13:31

April 29 (Reuters) - AtriCure Inc  ATRC.O :
    * ATRICURE’S EPI-SENSE SYSTEM APPROVED BY FDA FOR TREATMENT
OF
LONG-STANDING PERSISTENT AFIB PATIENTS

Source text for Eikon:  ID:nBw39tsnPa 
Further company coverage:  ATRC.O 

 ((Reuters.Briefs@thomsonreuters.com;))